17-8173532-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_183065.4(TMEM107):c.*671G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000301 in 765,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
TMEM107
NM_183065.4 3_prime_UTR
NM_183065.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.23
Genes affected
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM107 | NM_183065.4 | c.*671G>A | 3_prime_UTR_variant | 5/5 | ENST00000437139.7 | NP_898888.1 | ||
SNORD118 | NR_033294.2 | n.57G>A | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM107 | ENST00000437139.7 | c.*671G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_183065.4 | ENSP00000402732 | P1 | ||
TMEM107 | ENST00000449985.6 | c.*720G>A | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000404753 | ||||
SNORD118 | ENST00000363593.1 | n.56G>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152168Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000259 AC: 6AN: 232100Hom.: 0 AF XY: 0.0000390 AC XY: 5AN XY: 128042
GnomAD3 exomes
AF:
AC:
6
AN:
232100
Hom.:
AF XY:
AC XY:
5
AN XY:
128042
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000294 AC: 18AN: 613148Hom.: 0 Cov.: 0 AF XY: 0.0000358 AC XY: 12AN XY: 335156
GnomAD4 exome
AF:
AC:
18
AN:
613148
Hom.:
Cov.:
0
AF XY:
AC XY:
12
AN XY:
335156
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74366
GnomAD4 genome
AF:
AC:
5
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Leukoencephalopathy with calcifications and cysts Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine | Apr 06, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 2016 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 28, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this variant affects SNORD118 function (PMID: 27571260). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 265786). This variant has been observed in individuals with leukoencephalopathy with calcifications and cysts (PMID: 27571260, 29984895, 33029936). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant occurs in the SNORD118 gene, which encodes an RNA molecule that does not result in a protein product. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at